Abdominal pain is the primary symptom of all IBS subtypes (IBS-C, IBS-D, and IBS-M), and is the number one reason patients seek treatment for their IBS. … Read more
In just a few short years, digital therapeutics (DTx) have become an exciting, incredibly competitive new frontier in healthcare. For those not familiar… Read more
Digital therapeutics (DTx)—software that delivers a clinical mechanism of action, either alone or in combination with other standard-of-care treatments… Read more
Chicago Bootcamps featured metaMe Health in their list of the 60 Chicago Startups to Watch in 2020. The list highlights the most promising companies… Read more
CHICAGO (October 31, 2019) — metaMe Health, Inc., a Chicago-based prescription digital therapeutics company committed to the treatment of gastrointestinal… Read more
metaMe Health, a Chicago-based prescription digital therapeutics company committed to the treatment of gastrointestinal (GI) conditions such as Irritable… Read more
metaMe Health was featured in a blog article on 4sighthealth.com entitled “Regulatory Chess: Positioning for Competitive Advantage,” written by David… Read more
metaMe Health was named a winner of the prestigious Sandoz Healthcare Access Challenge (Sandoz HACk) for the company’s lead product Regulora®… Read more
Chicago-based metaMe Health announced that the company’s lead product Regulora®, a fully digital behavioral intervention for the treatment… Read more
Chicago-based metaMe Health has announced the appointment of Tim Rudolphi as its Chief Executive Officer (CEO). metaMe’s mission is to create… Read more